Michel P. Hermans

The normal-weight type 2 diabetes phenotype revisited.

M. Rousseau, M. Hermans, Sylvie A. Ahn, 2016, Diabetes & metabolic syndrome.

Size, density and cholesterol load of HDL predict microangiopathy, coronary artery disease and β-cell function in men with T2DM.

M. Rousseau, M. Hermans, Sylvie A. Ahn, 2017, Diabetes & metabolic syndrome.

What is the phenotype of patients with gastrointestinal intolerance to metformin?

M. Rousseau, M. Rousseau, M. Hermans, 2013, Diabetes & metabolism.

log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males

M. Rousseau, Sylvie A. Ahn, Michel P. Hermans, 2010, Cardiovascular diabetology.

Metabolic syndrome in Bantu subjects with type 2 diabetes from sub-Saharan extraction: Prevalence, gender differences and HOMA hyperbolic product

M. Hermans, S. Haumont, K. D. Amoussou-Guenou, 2008 .

Do high ferritin levels confer lower cardiovascular risk in men with Type 2 diabetes?

M. Hermans, M. Rousseau, M. Rousseau, 2010, Diabetic medicine : a journal of the British Diabetic Association.

The elusive type 2 diabetes individual achieving tight blood pressure target: A phenotypic study

M. Rousseau, M. Hermans, A. Aerts, 2010 .

Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence

F. Sacks, M. Rousseau, M. Hermans, 2011, Cardiovascular diabetology.